Showing 1001-1010 of 18563 results for "".
How to Identify & Manage Patients with Progressive-Fibrosing ILD
https://reachmd.com/programs/cme/how-to-identify-and-manage-patients-with-progressive-fibrosing-ild/10942/ILD diagnosis is complex and management can be tricky. Hear how to navigate this path and how the patient’s perspective can influence the care plan.Managing Chronic Graft-Versus-Host Disease with CSF1R Inhibition
https://reachmd.com/programs/project-oncology/managing-chronic-graft-versus-host-disease-with-csf1r-inhibition/36316/Chronic graft-versus-host disease (cGVHD) presents a significant clinical challenge due to its complex immune pathology and persistent fibrosis. Additionally, because conventional therapies often fall short, many patients are left with limited options and ongoing quality-of-life issues. Joining Dr.DESTINY-Breast05: Additional Data From the Interim Analysis
https://reachmd.com/clinical-practice/oncology-hematology/destiny-breast05-additional-data-from-the-interim-analysis/49126/Check out the interim DESTINY-Breast05 analysis of T-DXd showing improved IDFS and manageable safety vs T-DM1 in high-risk HER2+ BC with residual disease.Innovations in Precision Medicine: Leveraging Guideline-Based Immunotherapy and Targeted Treatments in Gynecologic Oncology
https://reachmd.com/programs/cme/Innovations-in-Precision-Medicine-Leveraging-Guideline-Based-Immunotherapy-and-Targeted-Treatments-in-Gynecologic-Oncology/37235/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
https://reachmd.com/programs/cme/from-flare-to-farewell-the-ibd-care-playbook-for-advanced-practice-providers/39248/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
https://reachmd.com/programs/cme/practical-strategies-for-optimizing-outcomes-in-patients-with-iron-deficiency-and-heart-failure/33043/Learn best practices to improve outcomes hospitalization rates in patients with iron deficiency and heart failure using intravenous iron.Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
https://reachmd.com/programs/cme/incorporating-guideline-recommended-targeted-therapies-into-rr-aml-management/36181/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.How Ichthyosis Can Affect Mental Health—And How We Can Address It
https://reachmd.com/programs/practical-dermatology/how-ichthyosis-can-affect-mental-health-and-how-we-can-address-it/24029/As a rare condition, ichthyosis can bring additional burdens upon patients and caregivers alike.FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
https://reachmd.com/programs/cme/fair-hf2-trial-ferric-carboxymaltose-assessment-of-morbidity-and-mortality-in-patients-with-iron-deficiency-and-chronic-heart-failure/33042/Learn how utilizing a more aggressive approach towards iron supplementation and deficiency may improve CV outcomes in patients with HFrEF; results from FAIR-HF2 study.The Critical Interplay: CKD, HF, and HyperkaleAmia
https://reachmd.com/programs/cme/the-critical-interplay-ckd-hf-and-hyperkalemia/36193/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.